Randomized Controlled Trial of Ultrasound-guided Versus Landmark Technique for Peripherally Inserted Central Catheter (PICC) Placement

NCT ID: NCT02859987

Last Updated: 2016-08-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

199 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Peripherally Inserted Central Catheter (PICC) are intravascular devices used on patients undergoing IV therapy. Insertion of these catheters can be achieved either by using the anatomical landmarks for the veins or using ultrasound guidance. The guidelines recommend the use of ultrasound guidance for central venous access catheterization to facilitate central venous cannulation (CVC) and to reduce the risk of complications, but the scientific evidence is limited and heterogeneous.

This is a prospective randomized clinical trial in adults patients requiring peripherally inserted central catheter (PICC) placement for intravenous therapy.

The principal aim of this randomized clinical trial is to evaluate the effectiveness of ultrasound-guidance technique for successfully peripherally central venous catheterisation in the first attempt versus landmark method, in the context of PICC cannulation.

Patients are randomized (1:1) in two groups: Control arm (landmark technique) versus Experimental group (ultrasound guidance technique). In order to avoid expected biases the investigators stratified the cases by difficulty for venous cannulation. Crossover was allowed if catheterisation could not be reached after two unsuccessful venipunctures, to prevent suffering of the patients and troubles in its care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PICC Placement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Landmark Technique

Blinded method for catheter placement

Group Type ACTIVE_COMPARATOR

PICC Placement by Landmark Technique

Intervention Type PROCEDURE

Comparison of two different techniques for PICC Placement (Landmark versus Ultrasound-guided)

Ultrasound-guided Technique

Use sonography for catheter placement

Group Type EXPERIMENTAL

PICC Placement by Ultrasound-guided Technique

Intervention Type PROCEDURE

Comparison of two different techniques for PICC Placement (Landmark versus Ultrasound-guided)

Ultrasound Scan

Intervention Type DEVICE

Initially the nurses use ultrasound for explore venous anatomy and then they use real-time ultrasound imaging during needle placement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PICC Placement by Landmark Technique

Comparison of two different techniques for PICC Placement (Landmark versus Ultrasound-guided)

Intervention Type PROCEDURE

PICC Placement by Ultrasound-guided Technique

Comparison of two different techniques for PICC Placement (Landmark versus Ultrasound-guided)

Intervention Type PROCEDURE

Ultrasound Scan

Initially the nurses use ultrasound for explore venous anatomy and then they use real-time ultrasound imaging during needle placement

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed and dated informed consent.
* Patients with indication of PICC insertion for long-term intravenous therapy

Exclusion Criteria

* Peripheral vascular disease
* Injecting drug users
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital San Carlos, Madrid

OTHER

Sponsor Role collaborator

Equipo de Terapia Intravenosa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria Montealegre, RN, IV Nurse

Role: STUDY_DIRECTOR

Hospital Universitario Clinico San Carlos

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ETI-HCSC-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.